The MosaiQ solution is a next-generation IVD solution for autoimmune diseases, allergies and beyond. The multiplexed, fully automated planar microarray platform enables syndromic testing for complex ...
All reagents and multiplex microarray magazines are equipped with RFID tags to save time while avoiding manual errors. Unique combination of tests The MosaiQ AiPlex CTDplus assay enables a syndromic ...
EYSINS, Switzerland, Feb. 10, 2025 /PRNewswire/ — AliveDx announces it has submitted 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for the MosaiQ AiPlex ® Celiac Disease ...
PathogenDx's breakthrough technology shifts the pathogen detection paradigm from microbial to molecular testing through its microarray assays, namely DetectX, EnviroX, and QuantX SANTA CLARA, ...
A new DNA sequencing process is simpler, more accurate and efficient than the multiplex PCR that was previously used to sequence portions of the genome. Microarrays are used to enrich or increase the ...
State-of-the-art facility offers increased capacity and enhanced process automation to meet the growing demand for Aushon's multiplex immunoassay products and services Billerica, Mass.,Sep 9, 2009 - ...
(*𝐍𝐎𝐓𝐄: 𝐓𝐨 𝐠𝐞𝐭 𝐜𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐭𝐨 𝐲𝐨𝐮𝐫 𝐥𝐢𝐤𝐢𝐧𝐠 𝐲𝐨𝐮 𝐜𝐚𝐧 𝐀𝐃𝐃 / 𝐑𝐄𝐌𝐎𝐕𝐄 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 ...
Analysis of gene expression is critical to understanding the molecular underpinnings of normal and disease processes. Although in recent years the field has been flooded with microarray data, a ...
The MosaiQ AiPlex CD is designed to improve the accuracy and speed of celiac disease diagnosis while simplifying laboratory workflows The MosaiQ AiPlex CD multiplex assay, which received IVDR-CE mark ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback